Physician profile
Thomas Snyder
NPI 1467949909
$2,161.67
in general payments reported to CMS, 2019-2025
11 companies · $1,980 in 2025
The $1,980 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $182 · 2025: $1,980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,097 · Travel and Lodging: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,096.66 |
| Travel and Lodging | $1,017.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,305.11 | 2025 | Pipeline, Solitaire X |
| Depuy Synthes Sales INC. | $186.74 | 2025 | Trufill, Embotrap, Cerepak Uniform |
| Astrazeneca Pharmaceuticals LP | $134.43 | 2024 | Andexxa |
| Stryker Corporation | $133.45 | 2025 | Surpass Evolve, Artix Mt |
| Microvention, INC. | $86.41 | 2025 | Balloon Catheter, Web Aneurysm Embolization System |
| Asahi Intecc USA, INC. | $78.95 | 2025 | Asahi Neurology Wires |
| Glaxosmithkline, LLC. | $67.58 | 2025 | Shingrix |
| Route 92 Medical, INC. | $61.59 | 2025 | |
| Imperative Care, INC | $26.29 | 2025 | Zoom Reperfusion Catheter |
| Ucb, INC. | $19.99 | 2025 | Fintepla |
| Abbvie INC. | $13.86 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.